Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup

Arthritis Care & Research
Jean SchmidtKenneth J Warrington

Abstract

To report a single-center experience with the use of tumor necrosis factor (TNF) inhibitors in patients with Takayasu arteritis (TA). We retrospectively studied a cohort of patients with refractory TA evaluated at our institution and treated with TNF inhibitors. American College of Rheumatology criteria for TA were used for inclusion. Disease activity was assessed according to the National Institutes of Health criteria. We included 20 patients (19 women, 17 white) with a mean ± SD age of 33 ± 10.2 years and a median disease duration of 15.9 months (interquartile range [IRQ] 2-32.7 months) prior to the use of TNF inhibitors. Before the use of TNF inhibitors, all 20 patients received prednisone. Other medication use included methotrexate (18 patients), azathioprine (5 patients), mycophenolate mofetil (3 patients), and cyclophosphamide (3 patients). Seventeen patients (85%) received infliximab, 2 patients (10%) received adalimumab, and 1 patient (5%) received etanercept. The median duration of treatment with TNF inhibitors was 23.0 months (IQR 8.7-38.9 months). Treatment with TNF inhibitors resulted in disease remission in 18 (90%) of 20 patients and sustained remission in 10 patients (50%). Ten (83%) of 12 patients were able to t...Continue Reading

Citations

Jun 22, 2012·Modern Rheumatology·Yoshiro HoraiAtsushi Kawakami
Dec 7, 2013·International Heart Journal·Yoshikazu NakaokaIssei Komuro
Apr 11, 2014·Mediators of Inflammation·Pierre-André Jarrot, Gilles Kaplanski
Dec 7, 2014·Zeitschrift für Rheumatologie·H-I Huppertz, H W Lehmann
Oct 25, 2014·Intractable & Rare Diseases Research·Enrico TombettiElena Baldissera
Jun 5, 2014·Current Cardiology Reports·Soumya ChatterjeeE Rene Rodriguez
Feb 18, 2016·Autoimmunity Reviews·Y FerfarD Saadoun
Sep 19, 2015·La Revue de médecine interne·G PazzolaC Salvarani
Feb 2, 2016·La Revue de médecine interne·T Mirault, E Messas
May 21, 2013·Revista clínica española·S Pérez-EstebanS Castañeda
Sep 25, 2012·Joint, Bone, Spine : Revue Du Rhumatisme·Nicola MarianiBérengère Aubry-Rozier
Oct 17, 2012·The Journal of Evidence-based Dental Practice·Joan Otomo-CorgelMark A Reynolds
Aug 29, 2012·La Presse médicale·Tristan Mirault, Joseph Emmerich
Apr 2, 2015·International Immunopharmacology·Javier LoriceraMiguel A González-Gay
May 31, 2015·La Presse médicale·Giulia PazzolaCarlo Salvarani
Feb 19, 2013·International Journal of Cardiology·Mitsuaki Isobe
Nov 29, 2013·Annals of the Rheumatic Diseases·Klaus W FrommerElena Neumann
May 31, 2016·Annals of Vascular Surgery·Raffaele SerraStefano de Franciscis
Jan 31, 2017·Arthritis & Rheumatology·Carol A LangfordUNKNOWN Vasculitis Clinical Research Consortium
Jul 5, 2019·Annals of the Rheumatic Diseases·Bernhard HellmichRaashid Ahmed Luqmani
Nov 7, 2020·Zeitschrift für Rheumatologie·J H SchirmerB Hellmich
Jan 21, 2020·Circulation Journal : Official Journal of the Japanese Circulation Society·Mitsuaki IsobeUNKNOWN JCS Joint Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

Related Papers

Rheumatology
Arsene MekinianClub Rhumatismes et Inflammation, French Vasculitis Study Group and Société Nationale Française de Médecine Interne
© 2022 Meta ULC. All rights reserved